Nuvation Bio Inc.·4

Jun 3, 6:36 PM ET

Hanley David C. 4

4 · Nuvation Bio Inc. · Filed Jun 3, 2021

Insider Transaction Report

Form 4
Period: 2021-06-01
Hanley David C.
CHIEF TECHNICAL OPERATIONS
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-06-01+250,000250,000 total
    Exercise: $13.60Exp: 2031-05-31Class A Common Stock (250,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-06-01+187,500187,500 total
    Exercise: $13.60Exp: 2031-05-31Class A Common Stock (187,500 underlying)
Footnotes (2)
  • [F1]25% of the shares subject to the option vest on June 1, 2022 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
  • [F2]The shares subject to the Options will vest based on the satisfaction of both time-based and performance-based vesting criteria.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_990242

    POA DOCUMENT